Business ❯Healthcare ❯Pharmaceuticals

Drug Development

Clinical Trials GLP-1 Drugs Anti-Obesity Drugs Alzheimer's Disease Pfizer Obesity Treatments Eli Lilly AbbVie Concussion Treatment Vaccine Rollout Pfizer Inc Oncology RELYVRIO Neuroplastogenic Therapeutics FDA Regulations Springworks Therapeutics Multiple Sclerosis Treatments Novartis Weight Loss Treatment Oral Weight Loss Pill Investment Plans Weight-Loss Drugs Weight Loss Drugs

BioNTech Announces Job Cuts Following Major Financial Losses

Biogen Reports Mixed Q4 Results and Lowers 2025 Outlook

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

AbbVie Stock Plummets After Schizophrenia Drug Trials Fail

Starboard Value Acquires $1 Billion Stake in Pfizer

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial

Biogen Raises 2024 Profit Forecast Following Strong Q2 Earnings

Roche Accelerates Development of Promising Weight-Loss Pills

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders

Weight-Loss Drug Market Heats Up as Prices Drop and New Treatments Emerge

Novartis Raises Full-Year Guidance Following Strong Q1 Performance